Drug & Medical Device Litigation 2009

Now in its 14th year, ACI’s DRUG AND MEDICAL DEVICE LITIGATION is regarded as THE must-attend industry event. Not only is the conference a gathering of the who’s who in product liability litigation, but our faculty of distinguished in-house and outside counsel and renowned federal and state jurists will provide practical insights and tactics for overcoming the litigation challenges faced by drug and device manufacturers. This year’s conference will take place at the Millennium Broadway Hotel on December 8-10 in New York City.

To prepare the drug and device industries for changes to the product liability landscape under a new administration, ACI’s 14th Annual DRUG AND MEDICAL DEVICE LITIGATION has been designed to provide veteran and first-time delegates with the knowledge and strategies needed to face new obstacles head-on. In addition to the expertise provided by our faculty of leading product liability litigators, our extensive and diverse in-house faculty speakers provide insights into the business implications of mass tort litigation as well as practical litigation approaches every defense counsel can employ.

Typically, over 500 drug and medical device industry professionals attend this conference, but the venue for the program, the Millennium Broadway Hotel, actually creates a close, convival atmosphere and allows you the opportunity to meet and talk with industry leaders. New York in December is when the industry comes together to learn the new developments in product liability litigation and what can be expected in the year to come – you cannot afford to miss this critical industry event

Topics at the 2009 Drug & Medical Device Litigation conference include:

• Ensuring Enforcement Activities do not Negatively Impact Product Liability Litigation and Vice Versa
• Successfully Asserting a Preemption Defense and Managing Industry/FDA Relationships in Post-Levine and Post- Riegel World
• Procedural Strategies for Winning Cases
• Managing Litigation in a New Economy:  Fighting Mounting Litigation With a Restricted Budget
• Disqualifying Plaintiff’s Experts
• Litigation Prevention and Risk Management:  Developing Risk Assessment Protocols to Reduce the Probability and Costs of Litigation
• Preparing for Anticipated Changes Under the New Administration
• View From the Bench – Judicial Views on Medical Products Litigation Today

The 2009 conference features faculty from these industry leaders:

Abbott Medical Optics, Inc., Allergan, Inc.,Bausch & Lomb Inc., Biomet, Inc., Boston Scientific, Eli Lilly and Company, Novartis Corporation, Pfizer Inc., Purdue Pharma L.P., Stryker, Wyeth

"This is an excellent conference with knowledgeable faculty who have hands-on experience in the complexities of drug and medical device litigations. It allows me to keep up to date on recent developments and provides an opportunity to meet senior practitioners in the field."

-Alice Barns Herrington, Woodward, Hobson & Fulton, L.L.P.